
Sign up to save your podcasts
Or


The controversial drug is back in the news. In the early days of the pandemic, President Trump and some doctors touted it as an effective treatment. But studies soon discredited the treatment. Now, in an unexpected twist, some research papers dismissing the drug have also been thrown in doubt. So how useful is Hydroxychloroquine and how reliable are the reviews we rely on to assess a drug's safety? Laura Carlson speaks to Bloomberg reporters Michelle Cortez and Robert Langreth for answers.
See omnystudio.com/listener for privacy information.
By Bloomberg3.7
805805 ratings
The controversial drug is back in the news. In the early days of the pandemic, President Trump and some doctors touted it as an effective treatment. But studies soon discredited the treatment. Now, in an unexpected twist, some research papers dismissing the drug have also been thrown in doubt. So how useful is Hydroxychloroquine and how reliable are the reviews we rely on to assess a drug's safety? Laura Carlson speaks to Bloomberg reporters Michelle Cortez and Robert Langreth for answers.
See omnystudio.com/listener for privacy information.

78,730 Listeners

32,255 Listeners

6,997 Listeners

28,977 Listeners

16,315 Listeners

2,679 Listeners

408 Listeners

2,173 Listeners

1,992 Listeners

437 Listeners

12,119 Listeners

17,589 Listeners

971 Listeners

113,520 Listeners

196 Listeners

30 Listeners

10,241 Listeners

4 Listeners

58 Listeners

233 Listeners

228 Listeners

69 Listeners

81 Listeners

86 Listeners

398 Listeners

21 Listeners

12 Listeners

8 Listeners

2 Listeners

123 Listeners

1,172 Listeners

184 Listeners